MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Phase 3
Completed
Conditions
Bipolar Disorder
First Posted Date
2002-05-03
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
338
Registration Number
NCT00035230

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Phase 4
Completed
Conditions
Alzheimer Disease
First Posted Date
2002-05-03
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
63
Registration Number
NCT00035204

The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Phase 3
Completed
Conditions
Schizophrenia
First Posted Date
2002-05-03
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
279
Registration Number
NCT00034749

A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX

Phase 3
Terminated
Conditions
Foot Ulcer
Diabetic Foot
Skin Ulcer
Diabetic Neuropathies
First Posted Date
2002-05-03
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
84
Registration Number
NCT00034788

A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting

Phase 3
Completed
Conditions
Pneumonia
First Posted Date
2002-05-03
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
691
Registration Number
NCT00034736
© Copyright 2025. All Rights Reserved by MedPath